Portable diagnostic test can help ID 16 pathogens in rural settings

Testing for multiple drug-resistant pathogens in rural parts of developing countries is often difficult due to the lack of laboratories and resources. Researchers have developed a portable detection system designed to improve care to these remote patients by identifying 16 different pathogens.

Of 1.5 billion people affected by microbial infections, many of them live in isolated communities without means of diagnosing these pathogens. Caregivers are often left to play a guessing game on what pathogen a patient has. The work was published Dec. 16 in the journal Applied and Environmental Microbiology.

“For example, when an infection's cause can't be identified with certainty, caregivers frequently use broad spectrum antibiotics to boost the probability of killing the pathogen. Unfortunately, as compared to precisely targeted antibiotics, the use of broad spectrum antibiotics increases the likelihood of spreading antimicrobial resistance genes,” said first author Lars D. Renner, PhD, Group Leader at the Leibniz Institute of Polymer Research, and the Max Bergmann Center of Biomaterials, Dresden, Germany.

The portable detection system is battery powered, small and easy to use. With 16 mirochambers, each containing a genetic sequence of each of the 16 pathogens it is meant to detect, the device only needs one drop of the patient’s sample to give a reading. These pathogens include: Enterococcus faeciumStaphylococcus aureusKlebsiella pneumoniaeAcinetobacter baumanniiPseudomonas aeruginosa and various species of the genus, Enterobacter.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”